Salvage cryotherapy for the localized recurrence prostate cancer after definitive radiotherapy, a prospective study

Salvage cryotherapy for the localized recurrence prostate cancer after definitive radiotherapy, a prospective study - Salvage cryotherapy for the localized recurrence prostate cancer after definitive radiotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018222

Enrollment

Registered

2015-07-07

Start date

2015-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The local recurrence prostatse cancer after definitive radiotherapy

Interventions

Cryotherapy

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) Local recurrence prostate cancer after definitive radiotherapy 2) No distant metastasis 3) The serum PSA level is less than 20 ng/ml before salvage Tx 4) PS 0-1 5) RV volume is less than 50ml 6) No hormone therapy before recurrence.

Exclusion criteria

Exclusion criteria: 1) Double cancer 2) The patient has uncontrol HT, DM and ischemic cardiac disease 3) Using steroid 4) Using hormone therapy within 3month before enrolled.

Design outcomes

Primary

Measure	Time frame
Biochemical free survival	—

Secondary

Measure	Time frame
1) Overall survival 2) Clinical progression free survival 3) Safety	—

Countries

Japan

Contacts

Public ContactKenta Miki

Jikei University School of Medicine Urology

kentamiki@gmail.com03-3433-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026